Repligen (RGEN) Competitor Comparison
We are evaluating the key criteria listed to compare Repligen (RGEN) against its competitors in the Medical Instruments & Supplies industry.
Market Capitalization
10 / 44Gross Profits
18 / 40Total Revenue
19 / 43EBITDA
19 / 44Free Cashflow
16 / 44Quick Ratio
22 / 44Earnings per Share
20 / 44Dividend yield
0 / 13Total Cash
10 / 44Performance 3 years
25 / 44Performance 5 years
6 / 44Performance 10 years
8 / 44Linearity 3 years
22 / 44Linearity 5 years
24 / 44Linearity 10 years
37 / 44Total Rank
25 / 44Dividend Rank
36 / 44Valuation Rank
40 / 44Piotroski Rank
20 / 44Muliplier Rank
23 / 44Linearity 5 years - RGEN ranking 24 / 44
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.